您好,欢迎来到阿仪网! 请登录 免费注册

  • 高级会员服务
  • |
  • 广告位服务
  • |
  • 设为首页
  • |
  • 收藏本站
  • |
  • 诚信档案

    • 会员类型:旗舰版会员
    • 阿仪网旗舰版会员:3年
    • 工商认证【已认证】
    • 最后认证时间:
    • 注册号: 【已认证】
    • 法人代表: 【已认证】
    • 企业类型:生产商 【已认证】
    • 注册资金:人民币万 【已认证】
    • 产品数:

上海富衡生物科技有限公司 主营产品:细胞株,原代细胞,永生化细胞,细胞培养试剂,转染试剂,污染清除试剂,诱导成脂,成骨,成软骨试剂,无血清冻存液,FBS

第3年

当前位置: 阿仪网 > 生命科学 > 细胞分析 > 细胞培养装置 > 上海富衡生物科技有限公司 > 产品展示 > 细胞库 > 人源细胞 > 人卵巢癌细胞SKOV3 (STR)FH0135

人卵巢癌细胞SKOV3 (STR)FH0135

价格:¥电议

品牌名称:富衡型号:FH0135 原产地:中国大陆 更新时间:2026/10/21 7:56:21

产品摘要:1973 年,该细胞系由 Fogh J 等人从一名 52 岁的卵巢浆液性囊腺癌患者的腹水中分离建立。SKOV3 细胞具有典型的卵巢癌细胞特征,在体外培养时呈上皮样形态,贴壁生长。它常被用于卵巢癌的基础研究,如肿瘤细胞的增殖、侵袭、转移机制的探索,以及抗卵巢癌药物的研发、药物敏感性测试等方面。由于其具有较高的侵袭和转移能力,在研究卵巢癌的恶性生物学行为方面具有重要作用。

支付方式:

  • 支付宝 微信 银行转账

产品完善度: 访问次数:601

企业档案

会员类型:旗舰版

已获得阿仪网信誉   等级评定
61成长值

(0 -40)基础信誉积累,可浏览访问

(41-90)良好信誉积累,可接洽商谈

(91+  )优质信誉积累,可持续信赖

阿仪网旗舰版会员:3年

工商认证 【已认证】

最后认证时间:

注册号: 【已认证】

法人代表: 【已认证】

参观次数:630295

手机网站:http://wap.app17.com/c171164/

旗舰版网址:http://www.fuhengcell.com

详细内容

富衡相关文献

产品名称人卵巢癌细胞;SKOV3 (STR)
品牌FuHeng
英文名SKOV3 (STR)
货号FH0135
规格1×10⁶cells/T25培养瓶
价格1300.0
培养McCoy's 5A+10%FBS
别称SKOV-3; SK-OV3; SK.OV.3; SKOV3; Skov3; SKO3
形态特征上皮样
生长特性贴壁生长
培养条件气相:空气,95%;CO2,5%温度:37℃
传代方法消化3-4分钟,1:2传代
组织来源卵巢浆液性囊腺癌
细胞简介1973 年,该细胞系由 Fogh J 等人从一名 52 岁的卵巢浆液性囊腺癌患者的腹水中分离建立。SKOV3 细胞具有典型的卵巢癌细胞特征,在体外培养时呈上皮样形态,贴壁生长。它常被用于卵巢癌的基础研究,如肿瘤细胞的增殖、侵袭、转移机制的探索,以及抗卵巢癌药物的研发、药物敏感性测试等方面。由于其具有较高的侵袭和转移能力,在研究卵巢癌的恶性生物学行为方面具有重要作用。
特征特性SK-OV-3由G.Trempe和L.J.Old在1973年从卵巢肿瘤病人的腹水分离得到此细胞对肿瘤坏死因子和几种细胞毒性药物包括白喉毒素、顺铂和阿霉素均耐受。在裸鼠中致瘤,且形成与卵巢原位癌一致的中度分化的腺癌。
培养基SKOV3完全培养基
论文标题DOI发表时间期刊影响因子作者列表
Iron Oxide-Based Surface-Enhanced Raman Spectroscopy Bioprobes for Detecting Tumor Cells in Serous Effusion10.1021/acs.analchem.5c074462026-01-20ANALYTICAL CHEMISTRY6.7Jiabao Guo, Lei Xu, Jing Wang, Xinyu Miao, Xiawei Xu, Aochi Liu, Li Sun, Yujiao Xie, Zhiwei Hou, Tianxiang Chen, Aiguo Wu, Jie Lin, Tianan Jiang
Regulation and reversal of paclitaxel resistance via the STAT1‑mediated apoptotic pathway in ovarian cancer10.3892/ijo.2025.58322025-12-05INTERNATIONAL JOURNAL OF ONCOLOGY4.9Fanchen Wang, Xiaolin Xu, Bin Guan, Xin Li, Jia Yuan, Wencai Guan, Junyu Chen, Jingyi Fang, Qi Lu, Guoxiong Xu
Structure-Guided Design of a Highly Selective PI3Kα Inhibitor Overcoming Metabolic Dysregulation with Potent Anti-breast Cancer Efficacy10.1021/acs.jmedchem.5c023522025-11-17JOURNAL OF MEDICINAL CHEMISTRY6.8Yi Hou, Han Qin, Xinqing Zheng, Yasheng Zhu, Xiao Wang, Liping Wang, Wenjian Min, Shuyang Cao, Peng Yang
TIMM8B promotes oxidative phosphorylation and glycolysis by inhibiting the mtROS/ASK1/JNK signaling pathway in ovarian cancer10.1186/s13062-025-00663-62025-07-01Biology Direct4.9Jia Yue, Liao Jiaqian, Yang Xiangqun, Hu Hongyan, Zhao Wentao, Zhao Liufang, Ai Conghui, Xue Yuanbo, Tan Shufen, Zhang Yi
Oncolytic vaccinia virus harboring aphrocallistes vastus lectin exerts anti-tumor effects by directly oncolysis and inducing immune response through enhancing ROS in human ovarian cancer10.1016/j.bbrc.2024.1503552024-07-04BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS2.5Guohui Zhang, Qiang Wang, Rentao Yuan, Yanan Zhang, Ke Chen, Jianlei Yu, Ting Ye, Xiaoyuan Jia, Yanrong Zhou, Gongchu Li, Kan Chen
Identification of necroptosis-related gene signatures for predicting the prognosis of ovarian cancer10.1038/s41598-024-61849-y2024-05-15Scientific Reports3.8Qin Yuling, Sheng Yawen, Ren Mengxue, Hou Zitong, Xiao Lu, Chen Ruixue
Inhibit ALDH3A2 reduce ovarian cancer cells survival via elevating ferroptosis sensitivity10.1016/j.gene.2023.1475152023-05-27GENE3.5Hao Dong, Linsheng He, Qiran Sun, Jiao Zhan, Jiaqi Li, Xiaoming Xiong, Lingling Zhuang, Shuqing Wu, Yuan Li, Chen Yin, Quan He
RETRACTED ARTICLE: ANGPTL4 functions as an oncogene through regulation of the ETV5/CDH5/AKT/MMP9 axis to promote angiogenesis in ovarian cancer10.1186/s13048-022-01060⁻⁷2022-12-14Journal of Ovarian Research5.506Liu Yinping, Yang Rui, Zhang Yan, Zhu Yaping, Bao Wei
Sulfated Polysaccharide From Undaria Pinnatifida Induces Apoptosis and Inhibits Proliferation, Migration, and Invasion in Ovarian Cancer via Suppressing the Hedgehog Signaling Pathway10.3389/fmats.2021.7950612021-12-13Frontiers in Materials3.515Yang Yi, Zhang Qin, Xu Yongping, Chen Gang, Qiu Yukuan
Identification of lncRNA-Associated ceRNA Network in High-Grade Serous Ovarian Cancer Metastasis10.2217/epi-2020-00972020-08-19Epigenomics4.112Xi Li, Sihui Yu, Rui Yang, Qi Wang, Xiangnan Liu, Mingjun Ma, Yanli Li, Sufang Wu
Exosomes released from M2 macrophages transfer miR-221-3p contributed to EOC progression through targeting CDKN1B10.1002/cam4.32522020-06-26Cancer Medicine3.491Xiaoduan Li, Meiling Tang
Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype10.1016/j.canlet.2018.08.0012018-08-08CANCER LETTERS6.491Xin Chen, Jieru Zhou, Xiaoduan Li, Xinjing Wang, Yingying Lin, Xipeng Wang
Suppression of endothelial cell migration by tumor associated macrophage-derived exosomes is reversed by epithelial ovarian cancer exosomal lncRNA10.1186/s12935-017-0430-x2017-06-06Cancer Cell International2.74Wu Quanfeng, Wu Xiaoli, Ying Xiang, Zhu Qinyi, Wang Xinjing, Jiang Lu, Chen Xin, Wu Yueqian, Wang Xipeng
Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization10.3892/or.2017.56972017-06-06ONCOLOGY REPORTS2.662Xin Chen, Xiang Ying, Xinjing Wang, Xiaoli Wu, Qinyi Zhu, Xipeng Wang
Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages10.18632/oncotarget.92462016-05-09Oncotarget5.008Xiang Ying, Quanfeng Wu, Xiaoli Wu, Qinyi Zhu, Xinjing Wang, Lu Jiang, Xin Chen, Xipeng Wang

图-2222.jpg

热门标签:人卵巢癌细胞SKOV3,SKOV3,,SKOV3,细胞

相关文章

快速导航

在线咨询5分钟应答

提交